The latest survey data show that on average every three minutes in the world there is a woman is diagnosed with breast cancer, and in the coastal areas of our country, the average per 1,000 among women, there is a breast cancer patients, the incidence of female breast cancer positive 3% to 4% annual growth rate rose sharply, the growth rate of 7.5% per annum of the city, the death rate increased by an average of 6.9% per annum. Experts pointed out that breast cancer patients often have little knowledge but because of fear or the wrong medicine, chaotic withdrawal, causing great harm.
1
× undue reliance on traditional Chinese medicine
√ treatment should be based on Western
Some patients with a tumor to chemotherapy or radiotherapy heard afraid, turned to Chinese medicine. Guangdong Medical Association credits will be chairman of breast disease, Professor Su Fengxi Affiliated Hospital of Sun Yat-sen Memorial director of breast medical oncology Express reporter said that over-reliance on traditional Chinese medicine and the Chinese as the primary treatment for his disapproval.
He said there was the four counties of the patient when he found a small tumor, her look of traditional Chinese medicine. Because of shyness, the doctor did not touch her breast exam, but let her go home a self-portrait, and gave her medicine. Later, the patient's tumor has grown into a whole big breasts, she was watching WM. Professor Su said that the clinic and some over-reliance on a single patient Chinese medicine treatment, some patients eat Chinese food endocrine originally put stop taking the medication without authorization, which may lead to the best timing of treatment is delayed.
Su Fengxi said cancer is a serious health problem that can affect survival, should be the main means of western medicine, Chinese medicine treatment can be combined to achieve better therapeutic effect. He pointed out that Western medicine treatment of chemotherapy, radiotherapy, endocrine therapy, the treatment of European and American countries Experience high incidence of breast cancer.
2
× endocrine drugs eat enough for five years
√ 5 years after dressing continue to eat can reduce the recurrence rate
Liu discovered long after breast cancer, she went to the hospital to find a specialist doctor, and took a single drug, the doctor told her to eat even five years after the drug's look. Five years later, Sharon without breaking the drug over a period of time to recurrence of breast cancer, she found a doctor again. Doctor sighed, when I asked you to find me taking five years later, how does not come? Should you stop the drug can stop own decisions. Su Fengxi believe that after five years of high-risk breast cancer patients should continue to eat endocrine drugs, but want to change another endocrine drugs.
3
× a drug continued to eat
√ perimenopausal and menopausal incumbent endocrine drugs
Lack of estrogen in postmenopausal women, and that her estrogen-dependent breast cancer should be all right? It is not. Experts point out that endocrine drugs currently used mainly tamoxifen and aromatase inhibitors, which is an aromatase inhibitor hormonal therapy for breast cancer research most active part, for the treatment of postmenopausal estrogen-dependent breast cancer patients. Su Fengxi noted that although a woman's ovaries do not produce estrogen after menopause, but other than ovarian estrogen still exist. Treatment he gives is: If the patient at the beginning of menopause has not received endocrine therapy, tamoxifen can be used for treatment, reducing estrogen stimulation of tumor cells. In the course of treatment the patient once menopause, you can switch to third-generation aromatase inhibitors, androgen can not be converted to estrogen. In the meantime, the patient should be closely linked with the attending physician, choose the appropriate timing of the dressing to minimize metastasis and recurrence and prolong life.